The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
The 1995 Pill scare and its aftermath: lessons learnt
Abstract
In October 1995 the Committee on Safety of Medicines sent a warning to British doctors and other health personnel cautioning them about the use of combined oral contraceptive pills containing the third generation progestagens desogestrel and gestodene. The Committee’ s restrictions were made on the basis of three epidemiological studies (the World Health Organization study the United Kingdom General Practice Research Database study and the Transnational study) which were at that time unpublished. These studies suggested a doubling of the risk of venous thromboembolism in women taking these preparations compared with those on combined oral contraceptives containing the second generation progestagens levonorgestrel and norethisterone. Unfortunately this information reached the media before the medical profession could take full possession of the facts. The media paid massive attention to the warning resulting in serious repercussions. In the aftermath of the Committee’s warning there was a reaction out of proportion to the clinical significance of the original data. Thousands of women abruptly stopped taking the Pill altogether. Doctors and health professionals were uncertain about the advice they should offer and they had to struggle to cope with yet another (and Britain’ s biggest) Pill scare. (excerpt)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reporting of a two-fold increase in thrombosis events in women who are taking oral contraceptives, rather than reporting an increase from about 1 in 7,000 to 2 in 7,000, resulted eventually in an increase in the pregnancy and abortion rates in the UK in 1995.17”
From Artificial Intelligence in Detecting Statistical Errors: Implications for Authors, Reviewers, and Editors (2025) · cites this paper as [17]
Citations
Cites
Jick, H., Jick, S. S., Myers, M. W., Vasilakis, C., & Gurewich, V (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 726
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 594
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91927-9 · Cited by 453
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
COMMITTEE ON SAFETY OF MEDICINES
SCOWEN, E. (1978) · British Journal of Anaesthesia · doi:10.1093/bja/50.12.1270-a · Cited by 296
First-time use of newer oral contraceptives and the risk of venous thromboembolism
Suissa, S., Blais, L., Spitzer, W. O., Cusson, J., Lewis, M., & Heinemann, L. (1997) · Contraception · doi:10.1016/s0010-7824(97)00119-4 · Cited by 191
Lewis, M. A., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Spitzer, W. O. (1996) · Contraception · doi:10.1016/0010-7824(96)00112-6 · Cited by 183
The use of oral contraceptives and the occurrence of acute myocardial infarction in young women
Lewis, M. A., Heinemann, L. A. J., Spitzer, W. O., MacRae, K. D., & Bruppacher, R. (1997) · Contraception · doi:10.1016/s0010-7824(97)00118-2 · Cited by 163
The risk of venous thromboembolism associated with low oestrogen oral contraceptives
Farmer, R. D. T., & Preston, T. (1995) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443619509015499 · Cited by 110
Risk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study
Thorogood, M., Mann, J. I., Murphy, M. S., & Vessey, M. P. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.1.48 · Cited by 90
Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies
Lidegaard, Ø., & Milsom, I. (1996) · Contraception · doi:10.1016/0010-7824(96)00035-2 · Cited by 62
Westhoff, C. L. (1996) · Contraception · doi:10.1016/0010-7824(96)00111-4 · Cited by 51
van Lunsen, H. W. (1996) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189609150654 · Cited by 30
Martin, R. M., Hilton, S. R., & Kerry, S. M. (1997) · Family Practice · doi:10.1093/fampra/14.4.279 · Cited by 28
Selective prescribing of third generation oral contraceptives (OCs)
Jamin, C., & de Mouzon, J. (1996) · Contraception · doi:10.1016/0010-7824(96)00120-5 · Cited by 27
Venous thromboembolism and oral contraceptives
Herings, R. M. C., Urquhart, J., & Leufkens, H. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77606-6 · Cited by 18
12% Of women stopped taking their pill immediately they heard CSM's warning
Hope, S. (1996) · BMJ · doi:10.1136/bmj.312.7030.576b · Cited by 11
Farmer, R. D. T., Lawrenson, R., & Hambleton, I. R. (1996) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.11661692.1996 · Cited by 11
(1997) · Contraception · doi:10.1016/s0010-7824(97)90006-8 · Cited by 1
Research works printed but not linked: 3
- Allison C., 1997, The British Journal of Family Planning, 23, 79
- Hope S., 1996, Lancet, 347, 576
- Weatherall M. W., 1996, The British Journal of Family Planning, 22, 151
Cited by
Ingram, L. A., Monroe, C. M., Wright, H., Burrell, A., Jenks, R. A., Cheung, S. K. S., & Friedman, D. B. (2021) · Frontiers in Education · doi:10.3389/feduc.2021.782674 · Cited by 21
Contraception for the older woman: an update
Bhathena, R. K., & Guillebaud, J. (2006) · Climacteric · doi:10.1080/13697130600857904 · Cited by 20
Self-citationIntelligent Risk Communication: Can it be Improved?
Czarnecki, A. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00001 · Cited by 11
Common errors in statistics and methods
Flom, P., Harron, K., Ballesteros, J., Kalinda, C., Koutoumanou, E., Miles, J., Nevitt, S. J., & Rohloff, P. (2024) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2024-002755 · Cited by 10
Alnaimat, F., AlSamhori, A. R. F., El Sharu, H., Othman, L., Oralbek, A., & Zimba, O. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e342 · Cited by 4
Metadata
- Authors
- BHATHENA, R. K.
- Corresponding author
- BHATHENA, R. K.
- Venue
- Journal of Obstetrics and Gynaecology
- Publisher
- Informa UK Limited
- Published
- 1998-01
- Volume
- 18
- Issue
- 3
- Pages
- 215-217
- ISSN
- 0144-3615 (ISSN-L)
- 1364-6893
- OpenAlex
- W2083462411
- Cited by
- 6
- References
- 22
- Citations by year
- 2025: 2 · 2024: 1 · 2021: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Obstetrics and Gynaecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- combined oral contraceptives, desogestrel, gestodene, third-generation progestogens, venous thromboembolism risk, Committee on Safety of Medicines, levonorgestrel, norethisterone, Clinical Practice Research Datalink, transnational research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.